Literature DB >> 22829020

Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.

Peter P Chen1, Jitandrakumar R Patel, Patricia A Powers, Daniel P Fitzsimons, Richard L Moss.   

Abstract

BACKGROUND: Cardiac myosin-binding protein C (cMyBP-C) is a sarcomeric protein that dynamically regulates thick-filament structure and function. In constitutive cMyBP-C knockout (cMyBP-C(-/-)) mice, loss of cMyBP-C has been linked to left ventricular dilation, cardiac hypertrophy, and systolic and diastolic dysfunction, although the pathogenesis of these phenotypes remains unclear. METHODS AND
RESULTS: We generated cMyBP-C conditional knockout (cMyBP-C-cKO) mice expressing floxed cMyBP-C alleles and a tamoxifen-inducible Cre-recombinase fused to 2 mutated estrogen receptors to study the onset and progression of structural and functional phenotypes caused by the loss of cMyBP-C. In adult cMyBP-C-cKO mice, knockdown of cMyBP-C over a 2-month period resulted in a corresponding impairment of diastolic function and a concomitant abbreviation of systolic ejection, although contractile function was largely preserved. No significant changes in cardiac structure or morphology were immediately evident; however, mild hypertrophy developed after near-complete knockdown of cMyBP-C. In response to pressure overload induced by transaortic constriction, cMyBP-C-cKO mice treated with tamoxifen also developed greater cardiac hypertrophy, left ventricular dilation, and reduced contractile function.
CONCLUSIONS: These results indicate that myocardial dysfunction is largely caused by the removal of cMyBP-C and occurs before the onset of cytoarchitectural remodeling in tamoxifen-treated cMyBP-C-cKO myocardium. Moreover, near ablation of cMyBP-C in adult myocardium primarily leads to the development of hypertrophic cardiomyopathy in contrast to the dilated phenotype evident in cMyBP-C(-/-) mice, which highlights the importance of additional factors such as loading stress in determining the expression and progression of cMyBP-C-associated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829020      PMCID: PMC3466088          DOI: 10.1161/CIRCULATIONAHA.111.089219

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

1.  Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein.

Authors:  D S Sohal; M Nghiem; M A Crackower; S A Witt; T R Kimball; K M Tymitz; J M Penninger; J D Molkentin
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

2.  Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.

Authors:  Hideshi Niimura; Kristen K Patton; William J McKenna; Johann Soults; Barry J Maron; J G Seidman; Christine E Seidman
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.

Authors:  Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

4.  Comparison of two murine models of familial hypertrophic cardiomyopathy.

Authors:  B K McConnell; D Fatkin; C Semsarian; K A Jones; D Georgakopoulos; C T Maguire; M J Healey; J O Mudd; I P Moskowitz; D A Conner; M Giewat; H Wakimoto; C I Berul; F J Schoen; D A Kass; C E Seidman; J G Seidman
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

5.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

6.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.

Authors:  Tetsuo Konno; Masami Shimizu; Hidekazu Ino; Toru Matsuyama; Masato Yamaguchi; Hidenobu Terai; Kenshi Hayashi; Tomohito Mabuchi; Masaru Kiyama; Kenji Sakata; Tatsumi Hayashi; Masaru Inoue; Tomoya Kaneda; Hiroshi Mabuchi
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

8.  Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy.

Authors:  Ray E Hershberger; Nadine Norton; Ana Morales; Duanxiang Li; Jill D Siegfried; Jorge Gonzalez-Quintana
Journal:  Circ Cardiovasc Genet       Date:  2010-03-09

9.  Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation.

Authors:  T Miller; D Szczesna; P R Housmans; J Zhao; F de Freitas; A V Gomes; L Culbreath; J McCue; Y Wang; Y Xu; W G Kerrick; J D Potter
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

10.  A highly efficient recombineering-based method for generating conditional knockout mutations.

Authors:  Pentao Liu; Nancy A Jenkins; Neal G Copeland
Journal:  Genome Res       Date:  2003-03       Impact factor: 9.043

View more
  19 in total

1.  Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy.

Authors:  Adam S Helms; Vi T Tang; Thomas S O'Leary; Sabrina Friedline; Mick Wauchope; Akul Arora; Aaron H Wasserman; Eric D Smith; Lap Man Lee; Xiaoquan W Wen; Jordan A Shavit; Allen P Liu; Michael J Previs; Sharlene M Day
Journal:  JCI Insight       Date:  2020-01-30

2.  Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate.

Authors:  Robrecht Thoonen; Shewit Giovanni; Suresh Govindan; Dong I Lee; Guang-Rong Wang; Timothy D Calamaras; Eiki Takimoto; David A Kass; Sakthivel Sadayappan; Robert M Blanton
Journal:  Circ Heart Fail       Date:  2015-10-18       Impact factor: 8.790

3.  Loss of myocardial retinoic acid receptor α induces diastolic dysfunction by promoting intracellular oxidative stress and calcium mishandling in adult mice.

Authors:  Sen Zhu; Rakeshwar S Guleria; Candice M Thomas; Amanda Roth; Fnu Gerilechaogetu; Rajesh Kumar; David E Dostal; Kenneth M Baker; Jing Pan
Journal:  J Mol Cell Cardiol       Date:  2016-08-15       Impact factor: 5.000

4.  Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy.

Authors:  Ranganath Mamidi; Jiayang Li; Kenneth S Gresham; Julian E Stelzer
Journal:  Pflugers Arch       Date:  2013-12-06       Impact factor: 3.657

Review 5.  Myofilament dysfunction as an emerging mechanism of volume overload heart failure.

Authors:  Kristin Wilson; Pamela A Lucchesi
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

6.  Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2.

Authors:  Francisco J Alvarado; J Martijn Bos; Zhiguang Yuchi; Carmen R Valdivia; Jonathan J Hernández; Yan-Ting Zhao; Dawn S Henderlong; Yan Chen; Talia R Booher; Cherisse A Marcou; Filip Van Petegem; Michael J Ackerman; Héctor H Valdivia
Journal:  JCI Insight       Date:  2019-03-05

7.  Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.

Authors:  David Barefield; Mohit Kumar; Joshua Gorham; Jonathan G Seidman; Christine E Seidman; Pieter P de Tombe; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2014-11-25       Impact factor: 5.000

8.  Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.

Authors:  Jiayang Li; Kenneth S Gresham; Ranganath Mamidi; Chang Yoon Doh; Xiaoping Wan; Isabelle Deschenes; Julian E Stelzer
Journal:  Int J Cardiol       Date:  2018-09-21       Impact factor: 4.164

Review 9.  Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.

Authors:  Amelia A Glazier; Andrea Thompson; Sharlene M Day
Journal:  Pflugers Arch       Date:  2018-11-20       Impact factor: 3.657

10.  LRRC10 is required to maintain cardiac function in response to pressure overload.

Authors:  Matthew J Brody; Li Feng; Adrian C Grimes; Timothy A Hacker; Timothy M Olson; Timothy J Kamp; Ravi C Balijepalli; Youngsook Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.